Breaking News Instant updates and real-time market news.

PFE

Pfizer

$33.56

-0.09 (-0.27%)

05:11
10/10/16
10/10
05:11
10/10/16
05:11

Pfizer announces Phase 3 S-TRAC clinical trial results

Pfizer announced results from the Phase 3 S-TRAC clinical trial, or Sunitinib Trial as Adjuvant Treatment of Renal Cancer, investigating SUTENT as adjuvant therapy. The trial showed SUTENT extended disease-free survival, or DFS, by more than one year versus placebo in patients who were at high risk for recurrence after surgical resection of renal cell carcinoma, or RCC. These results will be presented today during a Presidential Symposium at the ESMO 2016 Congress, the annual meeting of the European Society for Medical Oncology being held in Copenhagen, Denmark. The results have also been published online by The New England Journal of Medicine. Adjuvant therapies are treatments that can be given to reduce the likelihood of the cancer returning after initial treatment such as surgery. The results from the S-TRAC trial showed that after one year of treatment, the median time until disease recurrence in participants treated with SUTENT after surgery was 6.8 years compared with 5.6 years for patients treated with placebo as assessed by independent central review, resulting in an overall risk reduction of 24 percent. At the time of the analysis, overall survival data was immature. Based on the results of S-TRAC, Pfizer is in discussions with global regulatory authorities to determine potential next steps.

  • 01

    Nov

PFE Pfizer
$33.56

-0.09 (-0.27%)

08/23/16
PIPR
08/23/16
NO CHANGE
PIPR
Pfizer acquisition 'a good fit strategically,' says Piper Jaffray
After Pfizer (PFE) agreed to buy Medivation (MDVN), Piper Jaffray analyst Richard Purkiss says that Pfizer has obtained Xtandi, "a blockbuster prostate cancer treatment," and "a close-to-market and late-stage pipeline." The analyst thinks that Xtandi's expansion to use in adjuvant prostate cancer could increase its sales by 65%-70%. He keeps a $54 price target and Overweight rating on Pfizer.
08/23/16
RHCO
08/23/16
DOWNGRADE
RHCO
Neutral
Medivation downgraded to Neutral from Buy at SunTrust
Medivation (MDVN) has agreed to be acquired by Pfizer (PFE) for $81.50 per share.
09/14/16
BMOC
09/14/16
NO CHANGE
BMOC
Pfizer should exceed fiscal 2016 guidance, says BMO Capital
BMO Capital analyst Alex Arfaei says that Pfizer should exceed its fiscal 2016 guidance. The analyst says that Medivation, which Pfizer agreed to acquire, gives Pfizer another growth driver. Additionally, Pfizer has a number of other "high margin specialty drugs," according to the analyst. He says that the stock's dividend yield is "attractive," and he keeps a $40 price target and Outperform rating on the shares.
10/07/16
ROTH
10/07/16
NO CHANGE
Target $160
ROTH
Buy
ICU Medical price target raised to $160 from $132 at Roth Capital
Roth Capital analyst Chris Lewis raised his price target for ICU Medical (ICUI) to $160 from $132 after the company announced an agreement to acquire Hospira Infusion Systems from Pfizer (PFE) for $1B. The analyst is overall positive on the deal as it removes the long-standing customer concentration overhang and grows ICU Medical into a legitimate pure-play infusion therapy company with a complete product portfolio. The company also preannounced Q3 preliminary results above expectations, he notes. Lewis reiterates a Buy rating on ICU Medical's shares.

TODAY'S FREE FLY STORIES

14:20
09/26/17
09/26
14:20
09/26/17
14:20
Conference/Events
FBN Securities strategist to hold an analyst/industry conference call »

Chief Market Strategist…

BLK

BlackRock

$434.46

-3.17 (-0.72%)

14:20
09/26/17
09/26
14:20
09/26/17
14:20
Options
Far upside call buyer in Blackrock opens a notable new position »

Far upside call buyer in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 22

    Oct

SYT

Syngenta

$92.07

-0.01 (-0.01%)

14:18
09/26/17
09/26
14:18
09/26/17
14:18
Hot Stocks
Syngenta reports pending settlement to resolve corn litigation »

Plaintiffs and defendants…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

14:17
09/26/17
09/26
14:17
09/26/17
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
09/26/17
09/26
14:16
09/26/17
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DAL

Delta Air Lines

$48.42

0.1 (0.21%)

14:10
09/26/17
09/26
14:10
09/26/17
14:10
Options
Delta calls outpace puts 10:1 as a bullish spread is opened »

Delta calls outpace puts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOH

Molina Healthcare

$65.78

1.24 (1.92%)

, UNH

UnitedHealth

$192.38

0.63 (0.33%)

14:09
09/26/17
09/26
14:09
09/26/17
14:09
Periodicals
GOP agrees not to vote on healthcare bill, CNN reports »

Senate Majority Leader…

MOH

Molina Healthcare

$65.78

1.24 (1.92%)

UNH

UnitedHealth

$192.38

0.63 (0.33%)

CNC

Centene

$92.15

1.82 (2.01%)

WCG

WellCare

$165.88

1.7305 (1.05%)

CI

Cigna

$183.10

1.66 (0.91%)

ANTM

Anthem

$183.18

1.68 (0.93%)

HNT

Health Net

HUM

Humana

$239.83

2.62 (1.10%)

AET

Aetna

$153.66

1.6785 (1.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

  • 04

    Oct

  • 17

    Oct

  • 24

    Oct

  • 08

    Nov

FL

Foot Locker

$34.77

0.11 (0.32%)

14:05
09/26/17
09/26
14:05
09/26/17
14:05
Options
Foot Locker call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXP

American Express

$88.48

0.27 (0.31%)

13:58
09/26/17
09/26
13:58
09/26/17
13:58
Hot Stocks
American Express raises quarterly dividend 9% to 35c per share »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 18

    Oct

  • 22

    Oct

FIT

Fitbit

$6.49

0.045 (0.70%)

13:57
09/26/17
09/26
13:57
09/26/17
13:57
Hot Stocks
Fitbit to participate in FDA software pilot program »

Fitbit announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 11

    Dec

FB

Facebook

$162.87

-7.67 (-4.50%)

, WMT

Wal-Mart

$79.48

0.33 (0.42%)

13:51
09/26/17
09/26
13:51
09/26/17
13:51
Hot Stocks
Wal-Mart to roll out Workplace by Facebook »

Julien Codorniou, the VP…

FB

Facebook

$162.87

-7.67 (-4.50%)

WMT

Wal-Mart

$79.48

0.33 (0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 03

    Oct

  • 08

    Oct

  • 10

    Oct

  • 22

    Oct

  • 16

    Nov

  • 21

    Nov

  • 20

    Feb

PTEN

Patterson-UTI

$20.47

0.94 (4.81%)

13:50
09/26/17
09/26
13:50
09/26/17
13:50
Options
Put buyers active in Patterson Energy »

Put buyers active in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$162.87

-7.67 (-4.50%)

, SLF

Sun Life Financial

$39.46

0.19 (0.48%)

13:49
09/26/17
09/26
13:49
09/26/17
13:49
Hot Stocks
Sun Life Financial announces launch of Workplace by Facebook »

Sun Life Financial (SLF)…

FB

Facebook

$162.87

-7.67 (-4.50%)

SLF

Sun Life Financial

$39.46

0.19 (0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 03

    Oct

  • 08

    Oct

  • 22

    Oct

ELF

e.l.f. Beauty

$19.68

-0.025 (-0.13%)

, WBA

Walgreens Boots Alliance

$78.96

0.55 (0.70%)

13:46
09/26/17
09/26
13:46
09/26/17
13:46
Recommendations
e.l.f. Beauty, Walgreens Boots Alliance analyst commentary  »

e.l.f. Beauty products…

ELF

e.l.f. Beauty

$19.68

-0.025 (-0.13%)

WBA

Walgreens Boots Alliance

$78.96

0.55 (0.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

13:45
09/26/17
09/26
13:45
09/26/17
13:45
General news
Fed funds futures slid lower on the heels of Yellen's comments »

Fed funds futures slid…

SRCI

SRC Energy

$9.18

0.36 (4.08%)

13:40
09/26/17
09/26
13:40
09/26/17
13:40
Options
Call writer opens a notable new position in SRC Energy as shares outperform »

Call writer opens a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 16

    May

HMNY

Helios and Matheson

$8.30

1.33 (19.08%)

13:40
09/26/17
09/26
13:40
09/26/17
13:40
Periodicals
Helios and Matheson mentioned cautiously by TheStreetSweeper 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDP

Meredith

$54.05

-0.35 (-0.64%)

13:31
09/26/17
09/26
13:31
09/26/17
13:31
Hot Stocks
Meredith names Alysia Borsa chief marketing and data officer »

Meredith Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BWP

Boardwalk Pipeline

$14.95

0.1734 (1.17%)

13:30
09/26/17
09/26
13:30
09/26/17
13:30
Options
In the money call buying continues in Boardwalk Pipeline »

In the money call buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:30
09/26/17
09/26
13:30
09/26/17
13:30
General news
More from Yellen: not much new in her Q&A, reiterating the two sided risks »

More from Yellen: not…

NKE

Nike

13:29
09/26/17
09/26
13:29
09/26/17
13:29
Periodicals
Nike: Code left company over 3 years ago, no longer an employee, Bloomberg says »

Merl Code, the former…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 03

    Oct

  • 04

    Oct

  • 10

    Oct

13:20
09/26/17
09/26
13:20
09/26/17
13:20
General news
Treasury Action: yields steadied below highs »

Treasury Action: yields…

$NSD

NASDAQ Market Internals

13:17
09/26/17
09/26
13:17
09/26/17
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

13:16
09/26/17
09/26
13:16
09/26/17
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$58.49

-0.06 (-0.10%)

13:15
09/26/17
09/26
13:15
09/26/17
13:15
Conference/Events
Target management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.